deepmeasures.health

What It Is

DEEP Measures focuses on the development, validation, and regulatory adoption of digital health measures. Its goal is to help clinical R&D teams start from sensor signals and build measurement approaches that are meaningful to patients, relevant to drug development, and acceptable to regulators. It is not a general-purpose project management SaaS product, but a specialized platform-plus-services offering for digital endpoints, sensor data, and clinical validation scenarios.

Core Capabilities

The website presents a “7-Steps” methodology covering Measure Definition, Regulatory Alignment, Solution Profile Definition, Solutioning, Analytical Validation, Clinical Validation, and Regulatory Qualification. This broadly maps to the full journey from concept definition to regulatory qualification. At the platform level, it includes Catalog, Builder, and Workspaces: Catalog is used to reuse measure definitions, solution profiles, and technical content; Builder helps assemble and customize measurement solutions for specific use cases; and Workspaces supports internal and external cross-functional teams in advancing projects together within a secure space. DEEP also provides business cases, measurement strategy, operational planning, content services, and regulatory content and communication support for FDA, EMA, and HTA Bodies, while emphasizing collaboration between experts and AI agents.

Pricing and Procurement

The public content does not disclose plans, pricing, a free version, or a trial. The site mainly directs users to request a demo and contact the team for consultation. As such, it appears closer to an enterprise, consultative sales model. Before procurement, buyers would need to clarify the scope of services, deliverables, platform seats, data processing arrangements, and compliance responsibilities through a demo or sales process.

Pros and Cons

Its strengths lie in its clear vertical focus. It covers the scientific, technical, analytical validation, clinical validation, and regulatory pathways involved in digital measure development, making it suitable for highly complex clinical projects. The reuse-oriented approach of Catalog and Builder may also help reduce duplicated effort. The main limitation is the lack of public detail: third-party integrations, APIs, deployment options, permission models, security certifications, and customer case studies are not clearly specified. References to a “secure space” and “safe deployment of AI” are still not enough to support a rigorous compliance assessment.

Who It’s For

DEEP Measures is suitable for pharmaceutical companies, medical device and digital health companies, clinical operations teams, and digital endpoint teams—especially organizations that need to turn wearable or sensor data into verifiable clinical measures and plan to engage with agencies such as FDA or EMA. If you only need standard collaboration, forms, or dashboard tools, it may not be the best fit.

Access in China and Alternatives

The public content does not mention access from mainland China, payment methods, or local support, so these remain unknown. If conducting clinical or real-world studies in China, it is advisable to also evaluate cross-border data transfer requirements, compliance approvals, and local vendor capabilities. Comparable options include international solutions such as Medidata, Veeva, Clario, and Huma, as well as China-based clinical digitalization vendors such as Taimei Technology and Jiahe Meikang.